Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y0HC
|
|||
| Drug Name |
PF-06671008
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
PfizerNew York, NY
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Placental cadherin (CDH3) | Target Info | Immunomodulator | [2] |
| KEGG Pathway | Cell adhesion molecules (CAMs) | |||
| Panther Pathway | Alzheimer disease-presenilin pathway | |||
| Cadherin signaling pathway | ||||
| Wnt signaling pathway | ||||
| Reactome | Adherens junctions interactions | |||
| WikiPathways | Hair Follicle Development: Induction (Part 1 of 3) | |||
| Cell junction organization | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.